Search research articles
Contact Us
Filters
Showing results (101-110 of 154) with videos related to
Page
of 16
Sort By:
International Journal of Cancer
|
June 15, 1988
Human ovarian tumors in primary culture: growth, characterization and initial evaluation of the response to cis platinum treatment in vitro
G Balconi, M Broggini, E Erba, et al.
Cancer Research
|
March 31, 2001
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms
S Marchini, G Damia, M Broggini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 2, 2000
Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines
G Razzini, C P Berrie, S Vignati, et al.
Cancer Research
|
September 15, 1987
In vitro and in vivo methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistant to chloroethylnitrosoureas
C V Catapano, M Broggini, E Erba, et al.
Leukemia & Lymphoma
|
August 23, 2000
Extranodal marginal zone B-cell lymphoma genotyping by Alu-polymerase chain reaction
F Bertoni, R Müllenbach, M Broggini, et al.
International Immunopharmacology
|
November 26, 2003
Effects of tramadol on synovial fluid concentrations of substance P and interleukin-6 in patients with knee osteoarthritis: comparison with paracetamol
M Bianchi, M Broggini, P Balzarini, et al.
International Journal of Cancer
|
July 3, 1997
Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53
F Vikhanskaya, L Clerico, M Valenti, et al.
Oncology Research
|
April 11, 2000
Microsatellite instability and frameshift mutations in genes involved in cell cycle progression or apoptosis in ovarian cancer
A M Codegoni, F Bertoni, G Colella, et al.
British Journal of Cancer
|
February 1, 1990
DNA damage and sequence specificity of DNA binding of the new anti-cancer agent 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis maleate)
M Broggini, J A Hartley, W B Mattes, et al.
Neoplasia (New York, N.Y.)
|
August 10, 2000
Driving p53 response to Bax activation greatly enhances sensitivity to taxol by inducing massive apoptosis
P De Feudis, S Vignati, C Rossi, et al.
Page
of 16
Search research articles
Search
Showing results (101-110 of 154) with videos related to
Sort By:
Page
of 16
International Journal of Cancer
|
June 15, 1988
Human ovarian tumors in primary culture: growth, characterization and initial evaluation of the response to cis platinum treatment in vitro
G Balconi, M Broggini, E Erba, et al.
Cancer Research
|
March 31, 2001
4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms
S Marchini, G Damia, M Broggini, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 2, 2000
Novel functional PI 3-kinase antagonists inhibit cell growth and tumorigenicity in human cancer cell lines
G Razzini, C P Berrie, S Vignati, et al.
Cancer Research
|
September 15, 1987
In vitro and in vivo methazolastone-induced DNA damage and repair in L-1210 leukemia sensitive and resistant to chloroethylnitrosoureas
C V Catapano, M Broggini, E Erba, et al.
Leukemia & Lymphoma
|
August 23, 2000
Extranodal marginal zone B-cell lymphoma genotyping by Alu-polymerase chain reaction
F Bertoni, R Müllenbach, M Broggini, et al.
International Immunopharmacology
|
November 26, 2003
Effects of tramadol on synovial fluid concentrations of substance P and interleukin-6 in patients with knee osteoarthritis: comparison with paracetamol
M Bianchi, M Broggini, P Balzarini, et al.
International Journal of Cancer
|
July 3, 1997
Mechanism of resistance to cisplatin in a human ovarian-carcinoma cell line selected for resistance to doxorubicin: possible role of p53
F Vikhanskaya, L Clerico, M Valenti, et al.
Oncology Research
|
April 11, 2000
Microsatellite instability and frameshift mutations in genes involved in cell cycle progression or apoptosis in ovarian cancer
A M Codegoni, F Bertoni, G Colella, et al.
British Journal of Cancer
|
February 1, 1990
DNA damage and sequence specificity of DNA binding of the new anti-cancer agent 1,4-bis(2'-chloroethyl)-1,4-diazabicyclo-[2.2.1] heptane dimaleate (Dabis maleate)
M Broggini, J A Hartley, W B Mattes, et al.
Neoplasia (New York, N.Y.)
|
August 10, 2000
Driving p53 response to Bax activation greatly enhances sensitivity to taxol by inducing massive apoptosis
P De Feudis, S Vignati, C Rossi, et al.
Page
of 16